Global Breast Reconstruction Market to Reach USD 4.7 Billion by 2032 with a 7.5% CAGR Driven by Rising Mastectomy Surgeries and Awareness

In 2022, the global Breast Reconstruction Market was valued at USD 3.7 billion, which is projected to grow to USD 4.7 billion by 2032. This market is expected to register a revenue CAGR of 7.5% during the forecast period due to various factors such as increasing mastectomy surgeries, rising prevalence of breast cancer, and increasing awareness of breast reconstruction techniques. The use of quick breast reconstruction treatments, as well as improvements in breast reconstruction methods and equipment, are also contributing to revenue growth.

Breast reconstruction is a surgical procedure that rebuilds a woman's breast after a mastectomy, lumpectomy, or other operation using implants, tissue expanders, and autologous tissue grafts, among other things. Breast cancer is becoming more prevalent globally, and so are mastectomy surgeries. The World Health Organization (WHO) has identified breast cancer as the most common disease in women worldwide. The market's revenue growth is being propelled by rising awareness of breast reconstruction techniques and their benefits, such as boosting a woman's self-esteem.

Technological advances in breast reconstruction methods and equipment, such as the use of 3D printing, as well as the development of new implant materials, are also driving revenue growth. 3D printing technology, for example, allows for the creation of specialized implants that perfectly match the patient's body, resulting in better outcomes and greater patient satisfaction.

Get Free Sample PDF (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/6273

Key players in the Breast Reconstruction Market -

• Allergan, Inc. (AbbVie Inc.)
• Mentor Worldwide LLC (Johnson & Johnson Services, Inc.)
• Sientra, Inc.
• GC Aesthetics plc
• Establishment Labs S.A.
• POLYTECH Health & Aesthetics GmbH
• RTI Surgical Holdings, Inc.
• Groupe Sebbin SAS
• Hans Biomed Co. Ltd.

The market's revenue growth is also being fueled by an increasing demand for quick breast reconstruction procedures. The mastectomy and immediate breast reconstruction procedures are performed simultaneously to reduce the number of surgeries and recovery periods. Immediate breast reconstruction also aids in the patient's psychological well-being by restoring her sense of femininity and wholeness.

The market's revenue growth is also being driven by an increase in demand for breast reconstruction procedures in developing countries like China and India. Due to their large populations and an increasing prevalence of breast cancer, these countries have a high demand for breast reconstruction surgeries. Additionally, the rapid expansion of healthcare infrastructure and an increase in healthcare expenditures in these countries are driving revenue growth.

However, high costs of breast reconstruction surgeries and a lack of insurance reimbursement could restrict the market's revenue growth. Furthermore, the risk of complications from breast reconstruction surgeries, such as infection, implant rupture, and capsular contracture, could also hinder revenue growth.

Segments Covered in the Report -

The breast reconstruction market can be categorized based on procedure type and end-use outlook.

Based on procedure type, the market can be classified into three categories: implant-based reconstruction, autologous reconstruction, and combined procedures. Implant-based reconstruction involves the use of implants to reconstruct the breast. Autologous reconstruction, on the other hand, uses the patient's own tissue, such as skin, fat, and muscle, to reconstruct the breast. Combined procedures use both implants and autologous tissue to reconstruct the breast.

Based on end-use outlook, the market can be segmented into hospitals, clinics, and ambulatory surgical centers. Hospitals are expected to account for the largest share of the market due to the availability of advanced infrastructure and the presence of skilled healthcare professionals. Clinics are also expected to have significant growth in the market as they offer convenient and cost-effective options for patients. Ambulatory surgical centers are expected to grow at a slower pace due to the limited availability of resources and infrastructure.

In terms of procedure type, implant-based reconstruction is expected to hold the largest market share due to its simplicity, shorter surgery time, and lower costs. However, autologous reconstruction is gaining popularity due to the long-term benefits, such as reduced risk of complications and improved aesthetic outcomes. Combined procedures are also expected to grow at a significant rate due to the advantages of both implant-based and autologous reconstruction techniques.

In terms of end-use outlook, hospitals are expected to remain dominant in the market due to the availability of skilled healthcare professionals and advanced infrastructure. Clinics are expected to grow at a faster rate due to their convenience and cost-effectiveness. Ambulatory surgical centers are expected to grow at a slower rate due to the lack of resources and infrastructure.

Access Full Report Description with Research Methodology and Table of Contents @ https://www.reportsanddata.com/report-detail/breast-reconstruction-market

In conclusion, the breast reconstruction market can be segmented based on procedure type and end-use outlook. Implant-based reconstruction is expected to hold the largest market share, while hospitals are expected to remain the dominant end-use outlook. However, clinics and ambulatory surgical centers are expected to grow at a faster pace due to their convenience and cost-effectiveness.

Strategic development:

AbbVie Inc. has successfully acquired Allergan, Inc. on May 8, 2020, which includes the latter's business in breast reconstruction. The acquisition is intended to broaden AbbVie's range of products in the breast reconstruction market.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/6273

Read More About: -

Injectable Drug Delivery Market - https://www.reportsanddata.com/report-detail/injectable-drug-delivery-market

Hospital Acquired Infections (HAIs) Diagnostics Market - https://www.reportsanddata.com/report-detail/hospital-acquired-infections-hai-diagnostics-market

Cartilage Repair Market - https://www.reportsanddata.com/report-detail/cartilage-repair-market

Alopecia Market - https://www.reportsanddata.com/report-detail/alopecia-market

Cell-based Assays Market - https://www.reportsanddata.com/report-detail/cell-based-assays-market

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports and Data | Web: www.reportsanddata.com
Check our upcoming research reports @ https://www.reportsanddata.com/upcoming-reports
Visit our blog for more industry updates @ https://www.reportsanddata.com/blogs

This release was published on openPR.